Supernus Pharma (SUPN) Tops Q3 EPS by 25c, updates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 40.33 -1.74 (4.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.07 | 52 Week High | $26.84 | |||
| Open | $41.68 | 52 Week Low | $9.51 | |||
| Day High | $41.95 | P/E | N/A | |||
| Day Low | $39.96 | EPS | $-2.62 | |||
| Volume | 467,028 | |||||
